연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1481 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse | Moon, Joon Ho | Moon, JH | 11 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse | Sohn, Sang Kyun | Sohn, SK | 12 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse | Mattsson, Jonas | Mattsson, J | 13 | Princess Margaret Hosp, Hans Messner Allogene Transplant Program, Div Med Oncol & Hematol, Toronto, ON, Canada | ||||||
| Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse | Kim, Dennis Dong Hwan | Kim, DDH | 14 | Princess Margaret Hosp, Hans Messner Allogene Transplant Program, Div Med Oncol & Hematol, Toronto, ON, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Garcia-Horton, Alejandro | Garcia-Horton, A | 1 | McMaster Univ, Juravinski Hosp, Dept Oncol, Ancaster, ON, Canada | AAE-4477-2021 | Garcia-Horton, Alejandro | ||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Garcia-Horton, Alejandro | Garcia-Horton, A | 1 | McMaster Univ, Canc Ctr, Dept Oncol, Ancaster, ON, Canada | AAE-4477-2021 | Garcia-Horton, Alejandro | ||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Ahmad, Imran | Ahmad, I | 2 | Hop Maison Neuve Rosemont, Montreal, PQ, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Lepic, Kylie | Lepic, K | 3 | McMaster Univ, Juravinski Hosp, Dept Oncol, Hamilton, ON, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Lepic, Kylie | Lepic, K | 3 | McMaster Univ, Canc Ctr, Dept Oncol, Hamilton, ON, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Lemieux, Christopher | Lemieux, C | 4 | CHU Quebec Univ Laval, Ctr Integre Cancerol, Quebec City, PQ, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Sanford, David | Sanford, D | 5 | Univ British Columbia, British Columbia & Vancouver Gen Hosp, Dept Med, Leukemia Bone Marrow Transplant Program,Div Hemato, Vancouver, BC, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Elemary, Mohamed | Elemary, M | 6 | Univ Saskatchewan, Prov Hematol & Blood & Marrow Transplant Program, Saskatchewan Canc Agcy, Saskatoon, SK, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Jamani, Kareem | Jamani, K | 7 | Univ Calgary, Tom Baker Canc Ctr, Cumming Sch Med, Calgary, AB, Canada | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Al Zahrani, Mohsen | Al Zahrani, M | 8 | Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Riyadh, Saudi Arabia | ||||||
| Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? | Alhumaid, Muhned | Alhumaid, M | 9 | King Fahad Med City, Dept Hematol, Riyadh, Saudi Arabia | AHA-2993-2022 | Alhumaid, Muhned |
페이지 이동: